Effectiveness and Safety of a Single-Pill Combination of Empagliflozin/Linagliptin in Individuals With Uncontrolled Type 2 Diabetes With CKD: A Single-Centre Outpatient Clinic Real-World Experience

IF 2.3 4区医学 Q3 ENDOCRINOLOGY & METABOLISM

Canadian Journal of Diabetes Pub Date : 2024-11-01 DOI:10.1016/j.jcjd.2024.09.063

SANJAY MAHAJAN

引用次数: 0

查看原文本刊更多论文

恩格列净/利拉利汀单药复方制剂在未获控制的 2 型糖尿病合并慢性肾脏病患者中的有效性和安全性：单中心门诊实际经验

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Canadian Journal of Diabetes ENDOCRINOLOGY & METABOLISM-

CiteScore

4.80

自引率

4.00%

发文量

130

审稿时长

54 days

期刊介绍： The Canadian Journal of Diabetes is Canada''s only diabetes-oriented, peer-reviewed, interdisciplinary journal for diabetes health-care professionals. Published bimonthly, the Canadian Journal of Diabetes contains original articles; reviews; case reports; shorter articles such as Perspectives in Practice, Practical Diabetes and Innovations in Diabetes Care; Diabetes Dilemmas and Letters to the Editor.